While we did not observe significant change in the infiltration pattern of TILs from LLC-1 tumor, we identified significant increase in both CD8 and CD4 T-cells in the combined treatment tumors, and CD8 in tumors treated with anti-PD-1 alone (Fig. 6i, j, Supplementary Fig. 7). The gene discussed is CD8A; the disease is neoplasm.